At the end of the summer, SynapCell is going to take part of the major event in neuropsychopharmacology: the annual ECNP congress, held this year in Amsterdam.

Established in 1987 at the instigation of European scientists, ECNP is committed to ensuring that advances in the understanding of brain function and human behavior are translated into better treatments and enhanced public health.

ENCP support innovative research, encourage scientific activities, promote the entry of young scientists into the field, provide guidance and information to the public…

SynapCell will be presenting its newly commercialized solutions for drug development in the field of cognitive disorders during the poster session.
We hope to have the pleasure to meet you there!